Is the Bayer DCA 2000 Acceptable as a Screening Instrument for the Early Detection of Renal Disease?

Annals of Clinical Biochemistry - United Kingdom
doi 10.1177/000456329903600315
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Changes in the EEG Amplitude as a Biomarker for Early Detection of Alzheimer's Disease

2016English

Screening for Early Detection of Breast Cancer

Research'n Practical Medicine Journal
2015English

SCreening for Occult REnal Disease (SCORED)

Archives of Internal Medicine
2007English

The Ethics of Screening for Early Intervention in HIV Disease.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1989English

Renal Disease Screening: A Potential Tool for Reducing Health Inequity

Sao Paulo Medical Journal
Medicine
2016English

Results of a Screening Program in Germany for Early Detection of Early Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
1999English

Biomarkers for the Early Detection and Progression of Alzheimer’s Disease

Neurotherapeutics
NeurologyPharmacology
2016English

The Early Detection and Prevention of Disease

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
1959English

A Short Screening Instrument for Poststroke Dementia : The R-Camcog

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy